According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings (TTM) are -A$32.46 M. In 2023 the company made an earning of -A$17.4 M an increase over its 2022 earnings that were of -A$29.83 M.The earnings displayed on this page is the company's Pretax Income.